Literature DB >> 10770993

Acetylcholine receptor extracellular domain determines sensitivity to nicotine-induced inactivation.

A Kuryatov1, F A Olale, C Choi, J Lindstrom.   

Abstract

We have shown previously that chronic exposure to submicromolar concentrations of nicotine permanently inactivates alpha4beta2 and alpha7 neuronal nicotinic acetylcholine receptors while alpha3beta2 acetylcholine receptors are resistant to inactivation. Phosphorylation of the large cytoplasmic domain has been proposed to mediate functional inactivation. Chimeric subunits consisting of human alpha4 sequence from their N-terminus to either the beginning of the first transmembrane domain or the large cytoplasmic domain and alpha3 sequences thereafter formed acetylcholine receptors with beta2 subunits which were as susceptible to nicotine-induced inactivation as wild-type alpha4 acetylcholine receptors. The converse chimeras, containing the N-terminal parts of the alpha3 subunit and the C-terminal parts of the alpha4 subunit, formed acetylcholine receptors with beta2 subunits which were as resistant to nicotine-induced inactivation as wild-type alpha3beta2 acetylcholine receptors. Thus, inactivation of acetylcholine receptors produced by chronic exposure to nicotine results primarily from effects of the agonist on the extracellular and transmembrane domains of the alpha subunit.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10770993     DOI: 10.1016/s0014-2999(00)00027-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

1.  Functional properties of human nicotinic AChRs expressed by IMR-32 neuroblastoma cells resemble those of alpha3beta4 AChRs expressed in permanently transfected HEK cells.

Authors:  M E Nelson; F Wang; A Kuryatov; C H Choi; V Gerzanich; J Lindstrom
Journal:  J Gen Physiol       Date:  2001-11       Impact factor: 4.086

2.  Regulation of the distribution and function of [(125)I]epibatidine binding sites by chronic nicotine in mouse embryonic neuronal cultures.

Authors:  Cristian A Zambrano; Rakel M Salamander; Allan C Collins; Sharon R Grady; Michael J Marks
Journal:  J Pharmacol Exp Ther       Date:  2012-04-24       Impact factor: 4.030

3.  Long-lasting enhancement of glutamatergic synaptic transmission by acetylcholine contrasts with response adaptation after exposure to low-level nicotine.

Authors:  R Girod; L W Role
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

4.  The additional ACh binding site at the α4(+)/α4(-) interface of the (α4β2)2α4 nicotinic ACh receptor contributes to desensitization.

Authors:  N Benallegue; S Mazzaferro; C Alcaino; I Bermudez
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

5.  Molecular determinants of subtype-selective efficacies of cytisine and the novel compound NS3861 at heteromeric nicotinic acetylcholine receptors.

Authors:  Kasper Harpsøe; Helle Hald; Daniel B Timmermann; Marianne L Jensen; Tino Dyhring; Elsebet Ø Nielsen; Dan Peters; Thomas Balle; Michael Gajhede; Jette S Kastrup; Philip K Ahring
Journal:  J Biol Chem       Date:  2012-12-10       Impact factor: 5.157

6.  86Rb+ efflux mediated by alpha4beta2*-nicotinic acetylcholine receptors with high and low-sensitivity to stimulation by acetylcholine display similar agonist-induced desensitization.

Authors:  Michael J Marks; Natalie M Meinerz; Robert W B Brown; Allan C Collins
Journal:  Biochem Pharmacol       Date:  2010-06-30       Impact factor: 5.858

7.  A Novel α2/α4 Subtype-selective Positive Allosteric Modulator of Nicotinic Acetylcholine Receptors Acting from the C-tail of an α Subunit.

Authors:  Jingyi Wang; Alexander Kuryatov; Zhuang Jin; Jack Norleans; Theodore M Kamenecka; Paul J Kenny; Jon Lindstrom
Journal:  J Biol Chem       Date:  2015-10-02       Impact factor: 5.157

8.  Sensorimotor gating is associated with CHRNA3 polymorphisms in schizophrenia and healthy volunteers.

Authors:  Nadine Petrovsky; Boris B Quednow; Ulrich Ettinger; Anne Schmechtig; Rainald Mössner; David A Collier; Kai-Uwe Kühn; Wolfgang Maier; Michael Wagner; Veena Kumari
Journal:  Neuropsychopharmacology       Date:  2010-03-10       Impact factor: 7.853

Review 9.  The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum.

Authors:  Sharon R Grady; Outi Salminen; Duncan C Laverty; Paul Whiteaker; J Michael McIntosh; Allan C Collins; Michael J Marks
Journal:  Biochem Pharmacol       Date:  2007-07-27       Impact factor: 5.858

Review 10.  The road to discovery of neuronal nicotinic cholinergic receptor subtypes.

Authors:  Allan C Collins; Outi Salminen; Michael J Marks; Paul Whiteaker; Sharon R Grady
Journal:  Handb Exp Pharmacol       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.